Vera Therapeutics, Inc. Class A Common Stock (VERA) is a publicly traded Healthcare sector company. As of September 16, 2026, VERA trades at $32.44 with a market cap of $2.45B and a P/E ratio of -7.20. VERA moved -3.86% today. Year to date, VERA is -33.51%; over the trailing twelve months it is +38.90%. Its 52-week range spans $18.53 to $56.05. Analyst consensus is strong buy with an average price target of $76.75. Rallies surfaces VERA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for VERA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $32.44 |
| Market Cap | $2.45B |
| P/E Ratio | -7.20 |
| EPS | $-4.66 |
| Dividend Yield | 0.00% |
| 52-Week High | $56.05 |
| 52-Week Low | $18.53 |
| Volume | 893.92K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-299.62M |
| Gross Margin | 0.00% |
12 analysts cover VERA: 0 strong buy, 11 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $76.75.